Botulinum Toxin Injection – Friday Pop Quiz 2/2/2023
A 56-year-old man with a history of lower lid blepharoplasty presents for follow-up 3 days after undergoing botulinum toxin injection into the lower eyelid for periocular rhytides. Which of the following is the most likely cause of the patient’s findings? A. Allergy to botulinum toxin B. Formation of festoon C. Infraorbital malar edema D. Normal physiologic changes E. Undiagno …
Patient Buzz: The Mind-Skin Connection | The Expert Weighs In
PsychodermatologyStylecaster recently posted an online article about psychodermatology. How do the mind and skin influence each other? What do we now know and what questions are still unanswered? How can dermatology clinicians best counsel their patients when the mind-skin connection is at work? For expert advice, I reached out to Steven Daveluy, MD, FAAD, associate professor and program director at Wayne St …
Psychodermatology
Bimekizumab-bkzx Therapeutic Cheat Sheet
BIMEKIZUMABBimekizumab (Bimzelx®) is a new injectable medication FDA approved for plaque psoriasis. It is the first and only FDA approved IL-17A and IL-17F inhibitor for this disease, but is also being used as an off-label option for other conditions including psoriatic arthritis and hidradenitis suppurativa. This Therapeutic Cheat Sheet will focus on the on and off label uses of bimekizumab.   Bimekizuma …
BIMEKIZUMAB
JDD Buzz Series: Oral Minoxidil Shortages After Media Attention
MINOXIDILMedia attention about oral minoxidil has impacted access to the hair loss drug in the Washington, D.C. area, according to a study published in the January issue of the Journal of Drugs in Dermatology. Researchers found shortages of the drug in D.C.-area pharmacies more than a year after an article about the treatment appeared in The New York Times. To find out more about oral minoxidil access, …
MINOXIDIL